Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.
Luke FrankiwArun SinghCole PetersBegoña Comin-AnduixBeata Berent-MaozMignonette MacabaliKiana ShammaieCrystal QuirosPaula Kaplan-LefkoIgnacio Baselga CarreteroAntoni RibasTheodore Scott NowickiPublished in: Journal for immunotherapy of cancer (2023)
NCT02775292.